Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface

John Wojcik(Merck & Co., Inc., Rahway, NJ, USA (United States)), Shohei Koide(NYU Langone Health)

Journal of Biological Chemistry

February 25, 2016

10.1074/jbc.m115.707901

Cited by 53

Related Papers

Inhibition of RAS function through targeting an allosteric regulatory site

|Nature Chemical Biology|2016|299

Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss

|Modern Pathology|2019|44

Characterization of the Raf Kinase Inhibitory Protein (RKIP) Binding Pocket: NMR-Based Screening Identifies Small-Molecule Ligands

|PLoS ONE|2010|35